Skip to main content
Premium Trial:

Request an Annual Quote

Galapagos to Use GeneGo's MetaCore Software in Drug Development Research

NEW YORK (GenomeWeb News) — GeneGo today said that Galapagos will use its MetaCore software for internal research across “several disease areas” including osteoporosis, osteoarthritis, and rheumatoid arthritis.
 
Galapagos has previously used its adenoviral technology to identify and validate targets in bone and joint diseases, and applying MetaCore to these targets “could allow us to gain valuable insights at the system level,” Galapagos said in a statement.
 
Financial terms of the agreement were not disclosed.

Filed under

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.